American Society of Clinical Oncology (ASCO)

Journal of Clinical Oncology (JCO) Podcast

Health EN ↓ 468 episoder

The Journal of Clinical Oncology Podcast presents analyses and discussions centered on the latest findings published in ASCO's flagship Journal of Clinical Oncology. Host Dr. Davide Soldato facilitates interviews and scholarly discourse on the most impactful published findings. The Journal of Clinical Oncology Podcast is the trusted resource that empowers you to integrate cutting-edge evidence into clinical practice. The year's fellows interview authors and summarize the top Journal of Clinical Oncology articles in the series, JCO Article Insights.

Husk å besøke podkastens nettsted og støtte skaperen: sites.libsyn.com

Forfatter

American Society of Clinical Oncology (ASCO)

Kategori

Health

Podkastens nettsted

sites.libsyn.com

Siste episode

8. okt 2026

Hvor kan du lytte?

Podkaster i appen Replaio Radio Kommer snart

Podkaster kommer snart til appen. Installer nå, og bli den første som ser en helt ny tilnærming til podkaster

Last ned på Google Play Installer gratis Android nesten 10 mill. nedlastinger · 4,8 i vurdering iOS snart

Episoder

Air Pollution and Breast Cancer Incidence 09.01.2025

Host Dr. Davide Soldato and his guests Dr. Ann Wu and Dr. Alexa White discuss the article " Air Pollution and Breast Cancer Incidence in the Multiethnic Cohort Study " and the editorial " Growing Evidence for the Role of Air Pollution in Breast Cancer Development "  TRANSCRIPT The guests on this podcast episode have no disclosures to declare.   Dr. Davide Soldato: Hello and welcome to JCO After Ho...

JCO Article Insights: Adoption of Capivasertib in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer – Efficacy, Toxicity and Treatment Sequencing 30.12.2024

In this JCO Article Insights episode, Giselle de Souza Carvalho provides a summary on  " Navigating Treatment Pathways in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies " by Bhardwarj, et al and " US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor–Positive, Human Epidermal...

Overcoming Barriers to Make Patient-Partnered Research a Reality 12.12.2024

Host Dr. Davide Soldato and guests Dr. Suzanne George and Liz Salmi discuss their JCO article "Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality" TRANSCRIPT TO COME Dr. Davide Soldato:  Hello and welcome to JCO 's After Hours , the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology . I am your host, Dr. Davi...

JCO Article Insights: Nivolumab + Relatlimab v Nivolumab + Ipilimumab in Melanoma 25.11.2024

In this JCO Article Insights episode, Rohit Singh provides a summary on " First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data ", by Long et al, published in the November issue of the Journal of Clinical Oncology . The article provides insights into the use of the two dual immu...

Quality of Treatment Selection 14.11.2024

Host Dr. Davide Soldato and Dr. Aaron Mitchell discuss the JCO article " Quality of Treatment Selection for Medicare Beneficiaries With Cancer" TRANSCRIPT Dr. Davide Soldato: Hello and welcome to JCO After Hours , the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology . I am your host, Dr. Davide Soldato, medical oncologist at Hosp...

JCO Article Insights: HLA-Mismatched Unrelated Donor HCT With PTCy 28.10.2024

In this JCO Article Insights episode, Alexandra Rojek provides a summary on "Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors" by Schaffer et al published in the Journal of Clinical Oncology July 17th, 2024. TRANSCRIPT Alexandra Rojek: Hello and welcome to JCO Article Insights . I'm y...

Adjuvant Pembrolizumab for High-Risk, dMMR Endometrial Cancer 16.10.2024

Dr. Shannon Westin and her guest, Dr. Brian  Slomovitz discuss the article "Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy For Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors" recently published in the JCO and presented at the 2024 International Gynecologic Cancer Society. TRANSCRIPT The guest's disclosures can be found i...

Combining Response and Toxicity Data to Implement Project Optimus 30.09.2024

In this JCO Article Insights episode, Subodh Selukar interviews author Dr. Robert Maki on " Combining Response and Toxicity Data to Implement Project Optimus " by Maki, et al published in the Journal of Clinical Oncology September 11, 2024. TRANSCRIPT Subodh Selukar: Welcome to this episode of JCO Article Insights . This is Subodh Selukar, JCO 's editorial fellow. Today, I am interviewing Dr. Robe...

CBT-I for Cancer-Related Cognitive Impairment 12.09.2024

Host Dr. Davide Soldato and Dr. Shelia Garland discuss the JCO article " Randomized Controlled Trial of Virtually Delivered Cognitive Behavioral Therapy for Insomnia to Address Perceived Cancer-Related Cognitive Impairment in Cancer Survivors ." TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Davide Soldato: Hello and welcome to JCO After Hours , the podcast where w...

JCO Article Insights: Assisted Reproduction in Breast Cancer Patients 26.08.2024

In this episode of JCO Article Insights, Dr. Giselle de Souza Carvalho interviews Dr. Hatem Azim and Dr. Ann partridge on their JCO article "Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy," TRANSCRIPT Giselle Carvalho: Welcome to the JCO Article Insights episode for the August issue of the Journal of Clin...

Multi-Cancer Early Detection Testing for High-Risk Patients 08.08.2024

Host Dr. Davide Soldato interviews Dr. Sana Raoof to discuss the JCO article Turning the Knobs on Screening Liquid Biopsies for High-Risk Populations: Potential for Dialing Down Invasive Procedures . TRANSCRIPT Dr. Davide Soldato:  Hello, and welcome to JCO After Hours , the podcast where we sit down with others from some of the latest articles published in the Journal of Clinical Oncology . I am...

JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade 29.07.2024

In this episode of JCO Article Insights, Rohit Singh interviews Dr. Ticiana Leal on the editorial, " Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade ." TRANSCRIPT The guests' disclosures can be found in the transcript. Dr. Rohit Singh: Hello and welcome to JCO's Article Insights . I am your host Rohit Singh and today we will be discussing the JCO article, " Back to the Drawing Bo...

Functional Disability Among US Cancer Survivors 11.07.2024

Dr. Shannon Westin and her guest, Dr. Chao Cao, discuss the paper " Prevalence and Cancer-Specific Patterns of Functional Disability Among US Cancer Survivors, 2017-2022 " recently published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare.  Dr. Shannon Westin: Hello, everyone, and welcome to another episode of JCO After Hours , the podcast where we get in dep...

CAR T-Cell Therapy for Richter's Transformation 24.06.2024

In this JCO Article Insights episode, Alexandra Rojek provides a summary on  "Anti-CD19 Chimeric Antigen Receptor T-cell therapy for Richter's Transformation: An International, Multicenter, Retrospective Study by Kittai, et al published in the Journal of Clinical Oncology March 29th, 2024.  TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Alexandra Rojek : Hello and welc...

EAZ171: Predictors of TIPN in Black Women with Breast Cancer 03.06.2024

Dr. Shannon Westin and her guest, Dr. Bryan Schneider discuss the article " ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-induced Peripheral Neuropathy in Black Women with Early Stage Breast Cancer " recently published in the JCO and presented at the 2024 ASCO Annual Meeting. TRANSCRIPT  The guest on this podcast episode has no disclosures to declare. Shannon Wes...

JCO Article Insights: Final Analysis of the Ro-CHOP Trial 27.05.2024

In this JCO Article Insights episode, Alexandra Rojek provides a summary on " Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial " by Camus et al published February 16th, 2024 and the associated editorial wri...

Methylphenidate for Fatigue in Advanced Cancer 17.05.2024

Dr. Shannon Westin and her guest, Dr. Patrick Stone, discuss the article, Methylphenidate Versus Placebo for Treating Fatigue in People with Advanced Cancer, a Randomized, Double-Blind, Multicenter Placebo-Controlled Trial , recently published in JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Shannon Westin: Hello, everyone, and welcome to another episode of JCO A...

Introducing JCO Oncology Advances with Dr. Jonathan Friedberg and Dr. Pamela Kunz 09.05.2024

JCO Editor in Chief, Dr. Jonathan Friedberg interviews Dr. Pamela Kunz, Editor in Chief of the new premier open access journal, JCO Oncology Advances . Dr. Friedberg and Dr. Kunz discuss what is to come from the journal and the benefits of an open access journal.  TRANSCRIPT Dr. Jonathan Friedberg: Hello and welcome to another episode of JCO After Hours . I'm your guest host, Jonathan Friedberg ,...

JCO Article Insights: Atezolizumab Plus Bevacizumab, Chemotherapy in EGFR, ALK NSCLC 29.04.2024

In this JCO Article Insights episode, Rohit Singh provides summary on two articles published in the April 10th issue of the Journal of Clinical Oncology. The first article, " Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04) " describes a randomized, open-label, multicenter, phase II...

Commonly Held Beliefs About Cancer Survivorship 11.04.2024

Dr. Shannon Westin and her guests, Dr. Emily S. Tonorezos and Dr. Michael Halpern, discuss their article, " Myths and Presumptions About Cancer Survivorship " recently published in the JCO. TRANSCRIPT The guests on this podcast episode have no disclosures to declare.    Shannon Westin: Hello, everyone, and welcome to another episode of JCO After Hours , the podcast where we go in depth on manuscri...

JCO Article Insights: Long Term Follow Up of the RESORT (E4402) and LYSA Study 25.03.2024

In this JCO Article Insights episode, Alexandra Rojek provides a summary on two long term follow studies: "Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study" by Sarkozy, et al published on December 18th, 2023 and " Long Term Follow Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Ritux...

Pembrolizumab in Patients With Advanced Cancers With HTMB 14.03.2024

Dr. Shannon Westin and her guests, Dr. Herbert Duvivier and Dr. Richard Schilsky, discuss the paper " Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study " published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare.  Shannon Westin: Hello, everyone, and welcome to ano...

JCO Article Insights: Axillary Soft Tissue Involvement and Breast Cancer Prognosis 26.02.2024

In this JCO Article Insights episode, Giselle de Souza Carvalho provides a summary on  " Pathologic Exploration of the Axillary Soft Tissue Microenvironment and Its Impact on Axillary Management and Breast Cancer Outcomes " by Naoum, et al and " Optimization of Breast Cancer Regional Nodal Management " by Braunstein et al published in the January 10, 2024 issue in Journal of Clinical Oncology. The...

Omission of Radiotherapy after Breast-Conserving Surgery 22.02.2024

Dr. Shannon Westin and her guest, Dr. Reshma Jagsi, discuss the paper " Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA " recently published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Shannon Westin: Hello, everyone, and welcome to another episode of JCO Af...

Costs of Cancer Prevention in CDH1 Variant Carriers 08.02.2024

Dr. Shannon Westin and her guests, Dr. Jeremy Davis and patient advocate Kathryn Carr, discuss the paper " Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy " recently published and printed in the JCO. TRANSCRIPT Shannon Westin: Hello, everyone, and welcome to another episode of JCO After Hours , the podcast where we get in depth on manuscripts that...

Hør på podkasten Journal of Clinical Oncology (JCO) Podcast i Replaio

Radio og podkaster i én app - gratis og uten registrering. Installer i dag, og ikke gå glipp av lanseringen

Last ned på Google Play

Replaio er ikke podkastutgiver; programnavn, omslag og lyd tilhører opphavspersonene og distribueres via offentlige RSS-feeder.